US Food and Drug Administrator

  • 29 Apr 2024

In April 2024, the US FDA refused 31% of spice shipments from MDH due to salmonella contamination, while Hong Kong and Singapore suspended sales of certain MDH and Everest products.

  • Refusal rate doubled since October 2023, affecting one-third of all shipments.
  • FDA inspections reveal hygiene concerns at MDH manufacturing plant.
  • FSSAI initiates quality checks for powdered spices nationwide.
  • Indian food exports refusal rate stands at 0.15% from the US FY20 to FY23.